Logo

Paired Ends: Aug 2, 2011

Aug 02, 2011
Premium

Craig Venter will be awarded the Dickson Prize in Medicine from the University of Pittsburgh for his contributions in sequencing and mapping the first draft of the human genome.

Venter is the founder and president of the J. Craig Venter Institute and founder and CEO of Synthetic Genomics. He holds a BS as well as a PhD in pharmacology and physiology from the University of California, San Diego.

Filed under

Clinical Sequencing
Sequencing
Tools & Technology
JCVI
University of Pittsburgh
ABRF
synthetic genomics
Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.